AI Article Synopsis
- The study aims to explore the links between abnormal iron metabolism and inflammation in patients with Parkinson's disease (PD) who also have rapid eye movement sleep behavior disorder (PRBD).
- Out of 210 PD patients, 31.90% were identified as having PRBD, which correlated with more severe motor and non-motor symptoms compared to those without RBD (NPRBD).
- Increased levels of iron and inflammatory markers in cerebrospinal fluid, as well as changes in serum levels, suggest a connection between iron accumulation and neuroinflammation in patients with PRBD.
Article Abstract
Objective: To investigate potential mechanisms involving abnormal iron metabolism and related inflammation in Parkinson disease (PD) patients with probable rapid eye movement sleep behavior disorder (PRBD).
Methods: Total 210 PD patients and 31 controls were consecutively recruited. PD patients were evaluated by RBD Screening Questionnaire (RBDSQ) and classified into PRBD and probable no RBD (NPRBD) groups. Demographics information were recorded and clinical symptoms were evaluated by series of rating scales. Levels of iron and related proteins and inflammatory factors in cerebrospinal fluid (CSF) and serum were detected. Comparisons among control, NPRBD and PRBD groups and correlation analyses between RBDSQ score and levels of above factors were performed.
Results: (1) The frequency of PRBD in PD patients is 31.90%. (2) PRBD group has longer disease duration, more advanced disease stage, severer motor symptoms and more non-motor symptoms than NPRBD group. (3) In CSF, levels of iron, transferrin, NO and IL-1β in PRBD group are prominently increased. RBDSQ score is positively correlated with the levels of iron, transferrin, NO and IL-1β in PD group. Iron level is positively correlated with the levels of NO and IL-1β in PD group. (4) In serum, transferrin level is prominently decreased in PRBD group. PGE2 level in PRBD group is drastically enhanced. RBDSQ score exhibits a positive correlation with PGE2 level in PD group.
Conclusions: PRBD is common in PD patients. PRBD group has severer motor symptoms and more non-motor symptoms. Excessive iron in brain resulted from abnormal iron metabolism in central and peripheral systems is correlated with PRBD through neuroinflammation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592206 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138997 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
Cortical Functional Connectivity Changes in the Body-First and Brain-First Subtypes of Parkinson's Disease.
Mov Disord
November 2024
Neurology Unit, Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.
Background: Rapid eye movement (REM) sleep behavior disorder (RBD) may precede motor symptoms in Parkinson's disease (PD) by years. According to a recent hypothesis, premotor RBD (pRBD) is a marker of the PD body-first subtype, where synucleinopathy originates from the peripheral autonomic nervous system. Conversely, in the brain-first subtype, pathology would arise in the brain.
View Article and Find Full Text PDFMultimodal MRI changes associated with non-motor symptoms of rapid eye movement sleep behaviour disorder in Parkinson's disease patients.
Neuroradiology
October 2024
Department of Radiology, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, Jiangsu, People's Republic of China.
Article Synopsis
- Parkinson's disease (PD) worsens when paired with rapid eye movement sleep disorder (RBD), leading to significant non-motor symptoms like sleep and emotional issues that impact quality of life.
- A study compared brain scans of 33 PD patients without RBD and 21 with probable RBD, revealing more severe grey matter loss and functional abnormalities in the latter group, especially in key brain areas involved in mood regulation.
- Results indicated a link between decreased brain function in the posterior cingulate cortex and higher depression scores in RBD patients, suggesting new insights into the effects of RBD on Parkinson's disease.
Orthostatic Hypotension: a clinical marker for the body-first subtype of patients with Parkinson's Disease.
NPJ Parkinsons Dis
September 2024
Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China.
Article Synopsis
- - The study focused on investigating how orthostatic hypotension (OH) relates to different subtypes of Parkinson's Disease (PD) by measuring blood pressure in patients before and after a levodopa test.
- - Researchers categorized 928 PD patients into three groups based on their OH status: spontaneous OH (SOH), levodopa-induced OH (LOH), and non-OH (NOH), finding that 24.1% had SOH, 34.6% had LOH, and 41.3% had NOH.
- - The findings revealed that both SOH and LOH were linked to factors like older age, more severe disease symptoms, and worse quality of life, suggesting that OH could be
Microstructural alterations of the hypothalamus in Parkinson's disease and probable REM sleep behavior disorder.
Neurobiol Dis
May 2024
Department of Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, 310009 Hangzhou, China; Joint Laboratory of Clinical Radiology, The Second Affiliated Hospital, Zhejiang University School of Medicine, 310009 Hangzhou, China. Electronic address:
Background: Whether there is hypothalamic degeneration in Parkinson's disease (PD) and its association with clinical symptoms and pathophysiological changes remains controversial.
Objectives: We aimed to quantify microstructural changes in hypothalamus using a novel deep learning-based tool in patients with PD and those with probable rapid-eye-movement sleep behavior disorder (pRBD). We further assessed whether these microstructural changes associated with clinical symptoms and free thyroxine (FT4) levels.
Cortical Macro- and Microstructural Changes in Parkinson's Disease with Probable Rapid Eye Movement Sleep Behavior Disorder.
Mov Disord
May 2024
Medical Psychology Unit, Department of Medicine, Institute of Neurosciences, University of Barcelona, Barcelona, Spain.
Background: Evidence regarding cortical atrophy patterns in Parkinson's disease (PD) with probable rapid eye movement sleep behavior disorder (RBD) (PD-pRBD) remains scarce. Cortical mean diffusivity (cMD), as a novel imaging biomarker highly sensitive to detecting cortical microstructural changes in different neurodegenerative diseases, has not been investigated in PD-pRBD yet.
Objectives: The aim was to investigate cMD as a sensitive measure to identify subtle cortical microstructural changes in PD-pRBD and its relationship with cortical thickness (CTh).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!